FANCONI ANEMIA
Clinical trials for FANCONI ANEMIA explained in plain language.
Never miss a new study
Get alerted when new FANCONI ANEMIA trials appear
Sign up with your email to follow new studies for FANCONI ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New transplant approach aims to fix immune system in rare diseases
Disease control Recruiting nowThis study tests a stem cell transplant using milder chemotherapy for people with certain immune deficiencies or bone marrow failure. The goal is to see if donor cells can take over the bone marrow and restore a working immune system. About 27 participants will be enrolled, and t…
Matched conditions: FANCONI ANEMIA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 08:55 UTC
-
New cell therapy aims to reduce chemo side effects for rare blood disease
Disease control Recruiting nowThis study tests a new way to do stem cell transplants for people with Fanconi Anemia, a rare genetic condition that causes bone marrow failure. Instead of strong chemotherapy, patients get a milder prep treatment that includes an experimental antibody called JSP191. The goal is …
Matched conditions: FANCONI ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: Porteus, Matthew, MD • Aim: Disease control
Last updated May 26, 2026 08:55 UTC
-
Breakthrough transplant aims to cut immune drugs and infections in bone marrow failure patients
Disease control Recruiting nowThis study tests a special stem cell transplant that removes certain immune cells to lower the need for strong anti-rejection drugs. It is for people with inherited bone marrow failure disorders like Fanconi anemia. The goal is to help the immune system recover faster and reduce …
Matched conditions: FANCONI ANEMIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New hope for fanconi anemia: gentler transplant may reduce side effects
Disease control Recruiting nowThis study tests a stem cell transplant using lower doses of chemotherapy for people with Fanconi anemia who don't have a perfectly matched donor. The goal is to reduce serious side effects while still helping the body accept new blood-forming cells. About 70 participants will re…
Matched conditions: FANCONI ANEMIA
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
New stem cell filter could reduce transplant complications for vulnerable patients
Disease control AVAILABLEThis expanded access program offers a special stem cell processing technique (CD34+ selection) to patients with severe combined immune deficiency, Fanconi anemia, dyskeratosis congenita, or sickle cell disease who are receiving a stem cell transplant. The method removes certain i…
Matched conditions: FANCONI ANEMIA
Sponsor: University of Florida • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New study aims to catch rare cancers early in fanconi anemia patients
Knowledge-focused Recruiting nowThis study follows people with Fanconi anemia, a genetic condition that raises the risk of squamous cell carcinoma, especially in the mouth, throat, and genital areas. Researchers will screen 200 participants aged 12 and older (and some younger children with symptoms) every year …
Matched conditions: FANCONI ANEMIA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 08:54 UTC
-
Massive study aims to unlock cancer secrets in rare bone marrow diseases
Knowledge-focused Recruiting nowThis study looks at why people with certain rare bone marrow conditions (like Fanconi anemia) have a higher chance of getting cancer. Researchers will follow up to 4,000 participants and their family members over time to track cancer rates and find genetic or environmental risk f…
Matched conditions: FANCONI ANEMIA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC
-
New study watches how rare disease patients handle cancer screening stress
Knowledge-focused Recruiting nowThis study looks at anxiety related to cancer screenings in adults with Fanconi anemia, a rare condition that raises cancer risk. Researchers will observe 20 participants during their regular screening visits, noting body language, worries, and the clinic environment. The goal is…
Matched conditions: FANCONI ANEMIA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
Blood disease genetics study seeks families to unlock hidden causes
Knowledge-focused Recruiting nowThis study collects blood, bone marrow, and other samples from people with non-cancerous blood diseases and their family members. Researchers will analyze genes to find causes of these diseases and why some people get sicker than others. The goal is to improve future diagnosis an…
Matched conditions: FANCONI ANEMIA
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC
-
Hunt for hidden cancer genes in families
Knowledge-focused Recruiting nowThis research study aims to discover new genes that may increase the risk of childhood cancer. Researchers will collect blood samples and health information from 1,500 people in families where cancer clusters. The goal is to build a registry and sample bank to help future diagnos…
Matched conditions: FANCONI ANEMIA
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC